Stoke Therapeutics, Inc. — Form 10-Q
Filed November 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Stoke Therapeutics signed a lease (Sept 2021) for 38,000 rentable sq ft at 45-47 Wiggins Avenue, Bedford MA at $52/sq ft/year base rent ($1,976,000 annually), with two amendments extending the term: First Amendment (Dec 2023) extended through Dec 2026 at $2,489,000–$2,563,670/year; Second Amendment (Aug 2026) added two-month extension through Feb 2027 at $320,458.76/month. Landlord is Xenon Property LLC (formerly ARE-MA Region No. 24 LLC). Tenant pays $494,000 security deposit and full building operating expenses (100% share); no additional rent increases in extension periods beyond stated amounts.
Why this rating
Real estate lease extension is routine operational document. At $592M market cap, ~$2.5M annual rent is <0.5% of company value; extension through Feb 2027 provides modest occupancy certainty but involves no material deal, financing, or business change.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.